Summary & Overview
HCPCS Level II Q4269: Surgraft XT, Per Square Centimeter (Graft Material)
HCPCS Level II code Q4269 represents Surgraft XT billed per square centimeter as an add-on graft material used alongside a primary surgical procedure. As an add-on code, it is intended to capture incremental supply costs for a graft product applied during surgery rather than standalone services. Nationally, add-on product codes like Q4269 matter because they affect facility and supplier billing, influence bundled payment calculations, and are relevant for device and supply cost management across payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical context, the typical sites of service where Surgraft XT is used, and the role of add-on supply codes in surgical billing. The publication outlines common modifiers associated with supply and procedure billing, how Q4269 is positioned relative to primary procedures, and what benchmarks and policy considerations to expect when evaluating reimbursement and coverage for graft materials.
This national summary provides clinical and billing context to support revenue cycle, coding, and supply chain stakeholders in identifying where Q4269 applies, what information payers commonly require, and what to review when reconciling claims that include add-on graft materials.
Billing Code Overview
HCPCS Level II code Q4269 describes Surgraft XT, billed per square centimeter as an add-on item to be listed separately in addition to the primary procedure. This product is a graft material applied in conjunction with a primary surgical procedure to cover or augment tissue defects.
Service type: Graft material / surgical adjunct
Typical site of service: Operating room or other procedural setting where the primary surgery is performed (inpatient or outpatient surgical facilities)
Clinical & Coding Specifications
Clinical Context
A 58-year-old male with a chronic full-thickness lower extremity wound following trauma and prior debridement presents for advanced wound reconstruction. The surgeon plans application of a bioengineered skin substitute product billed under Q4269 (Surgraft XT, per square centimeter) as an add-on to the primary operative procedure. The clinical workflow includes preoperative wound assessment and measurement, operative debridement and hemostasis, preparation of the wound bed, and placement of the Surgraft XT graft material sized and documented in square centimeters. Intraoperative documentation records the exact square centimeters applied, the primary procedure that provided the surgical wound bed (for example, split-thickness skin graft placement or flap coverage), and any intraoperative events. Postoperative care includes dressing changes, wound assessments at follow-up visits, and documentation of graft take and any complications. Billing uses Q4269 as an add-on supply code reported in addition to the primary surgical procedure CPT code(s).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier / not otherwise specified | Use when no specific HCPCS modifier applies and the payer requires a default modifier if requested; rarely used clinically. |